ACADIA Pharmaceuticals
ACAD
#3710
Rank
S$4.73 B
Marketcap
S$27.40
Share price
0.82%
Change (1 day)
-5.16%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2023 (TTM): S-$1.24

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is S$2.88. In 2022 the company made an earnings per share (EPS) of S-$1.72 a decrease over its 2021 EPS that were of S-$1.34.

EPS history for ACADIA Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$1.24-27.67%
2022S-$1.7227.62%
2021S-$1.34-41.67%
2020S-$2.3012.5%
2019S-$2.05-17.95%
2018S-$2.50-17.02%
2017S-$3.010.43%
2016S-$3.0043.56%
2015S-$2.0973.4%
2014S-$1.20113.64%
2013S-$0.5618.92%
2012S-$0.47-15.91%
2011S-$0.56-210%
2010S$0.51-133.61%
2009S-$1.52-30.81%
2008S-$2.207.5%
2007S-$2.05-0.62%
2006S-$2.064.55%
2005S-$1.97-14.61%
2004S-$2.31-84.26%
2003S-$14.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.56 197.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$0.97-66.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.51 1,271.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.79 100.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
S-$5.93-305.78%๐Ÿ‡บ๐Ÿ‡ธ USA